Trial of Rectal Indomethacin to Prevent Acute Pancreatitis
Randomized Trial of Rectal Indomethacin to Prevent Acute Pancreatitis in Patients Undergoing Endoscopic Ultrasound-guided Fine Needle Aspiration of Pancreatic Cysts
-
Clinical Trial Information
Trial Contact: Garcia de Djuro, Ginette; Britton, David ; Shepherd, Adriane R
Trial Phone: 321.841.6649 ; 321.841.2684 ; 321 841-2285
-
IRB No: 22.085.04
Protocol Abbrev: RECTAL-INDO-PAN-CYSTS
Principal Investigator: Ji Young Bang, MD
Age Group: Adult
Secondary Protocol No: 22.085.04
Treatment: Drug: Indomethacin rectal suppositories
Therapies Involved: Medication
ClinicalTrials.gov ID: NCT05572788
-
Objective
The primary outcome measure is to compare the rate of post-procedure pancreatitis following EUS-guided fine needle aspiration of pancreatic cysts between the indomethacin group and placebo group.
-
Key Eligibility
1. Age ≥ 18 years
2. Suspected or confirmed pancreatic cyst seen on imaging, requiring EUS-FNA
